Indivior Pharmaceuticals, Inc. (INDV)

Indivior Pharmaceuticals Revenue

Indivior Pharmaceuticals had revenue of $317.00M in the quarter ending March 31, 2026, with 19.17% growth. This brings the company's revenue in the last twelve months to $1.29B, up 10.34% year-over-year. In the year 2025, Indivior Pharmaceuticals had annual revenue of $1.24B with 4.29% growth.

• Revenue (ttm): $1.29B
• Revenue Growth: +10.34%
• P/S Ratio: 3.95
• Revenue / Employee: $1,539,379
• Employees: 838
• Market Cap: 5.10B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.24B	51.00M	4.29%
Dec 31, 2024	1.19B	95.00M	8.69%
Dec 31, 2023	1.09B	192.00M	21.31%
Dec 31, 2022	901.00M	110.00M	13.91%
Dec 31, 2021	791.00M	144.00M	22.26%
Dec 31, 2020	647.00M	-138.00M	-17.58%
Dec 31, 2019	785.00M	-220.00M	-21.89%
Dec 31, 2018	1.01B	-88.00M	-8.05%
Dec 31, 2017	1.09B	35.00M	3.31%
Dec 31, 2016	1.06B	44.00M	4.34%
Dec 31, 2015	1.01B	-101.00M	-9.06%
Dec 31, 2014	1.12B	-101.00M	-8.31%
Dec 31, 2013	1.22B	-123.00M	-9.19%
Dec 31, 2012	1.34B	85.00M	6.78%
Dec 31, 2011	1.25B	-	-

Data Source: Fiscal.ai Last updated: Apr 30, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 29, 2026

Data Sources Report a data error